These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12688335)
1. Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab. D'Arena G; Luigiavigliotti M; Coccaro M; Iodice G; Tartarone A; Matera R; Di Renzo N Leuk Lymphoma; 2003 Mar; 44(3):561-2. PubMed ID: 12688335 [No Abstract] [Full Text] [Related]
2. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170 [TBL] [Abstract][Full Text] [Related]
3. Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation? Magagnoli M; Balzarotti M; Castagna L; Rahal D; Siracusano L; Nozza A; Santoro A Leuk Lymphoma; 2003 Sep; 44(9):1639-40. PubMed ID: 14565674 [No Abstract] [Full Text] [Related]
4. The use of vincristine in refractory auto-immune thrombocytopenic purpura. Van Zyl-Smit R; Jacobs P S Afr Med J; 1974 Oct; 48(48):2039-41. PubMed ID: 4474709 [No Abstract] [Full Text] [Related]
5. Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence. Ambriz-Fernández R; Chávez-Sánchez G; Pizzuto-Chávez J; Morales-Polanco MR; Aviles-Miranda A Arch Invest Med (Mex); 1985; 16(3):295-304. PubMed ID: 3833096 [No Abstract] [Full Text] [Related]
6. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147 [TBL] [Abstract][Full Text] [Related]
7. Rituximab for chronic immune thrombocytopenic purpura. Bay A; Oner AF J Pediatr; 2006 Mar; 148(3):423-4; author reply 424. PubMed ID: 16615987 [No Abstract] [Full Text] [Related]
8. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP). Gómez-Almaguer D Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772 [TBL] [Abstract][Full Text] [Related]
9. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia. Faurschou M; Hasselbalch HC; Nielsen OJ Eur J Haematol; 2001 Jun; 66(6):408-11. PubMed ID: 11488941 [TBL] [Abstract][Full Text] [Related]
16. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura. Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149 [TBL] [Abstract][Full Text] [Related]
17. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura. Aggarwal A; Catlett JP South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights. Silverman GJ Front Biosci; 2007 Jan; 12():2194-206. PubMed ID: 17127456 [TBL] [Abstract][Full Text] [Related]
19. Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Brennan MF; Rappeport JM; Moloney WC; Wilson RE Am J Surg; 1975 Apr; 129(4):490-2. PubMed ID: 1092196 [No Abstract] [Full Text] [Related]